Results 281 to 290 of about 1,754,298 (385)
Mesenchymal stem cells improve ovarian function by suppressing fibrosis through CTGF/FAK signalling in systemic lupus erythematosus. [PDF]
Zhang H+7 more
europepmc +1 more source
The Composition of Tracheobronchial Secretions in Cystic Fibrosis [PDF]
Warren S. Chernick, Lynne Reid
openalex +1 more source
Predicting immune responses to treatments, including nanomedicines, with high throughput test is challenging due to the immunoreactome's complexity and plasticity. A predictive screening platform integrating pathway activation and gene profiling in macrophages has been developed as a versatile tool for designing effective immunotherapies.
Sonia Becharef+12 more
wiley +1 more source
Urinary long non-coding RNA GAS5 as a noninvasive diagnostic biomarker for renal fibrosis. [PDF]
Yu Y, Niu YY, Zhang YY, Yu C.
europepmc +1 more source
Current preclinical studies of AAV‐mediated gene therapy explore different strategies based on the characteristics of inner ear diseases. For genetic hearing loss, approaches include the replacement of a “good gene,” removal of a “bad gene,” or direct correction of mutations through base editing.
Fan Wu+7 more
wiley +1 more source
LRRC8A Regulates Outer Hair Cell Volume and Electromotility and is Required for Hearing
This study identifies LRRC8A‐dependent volume‐regulated anion channels (VRACs) as essential for cochlear outer hair cells' electromotility and auditory signal amplification. LRRC8A deficiency disrupts cell volume control, impairs auditory sensitivity, and causes deafness, while targeted LRRC8A re‐expression restores auditory function.
Shengnan Wang+15 more
wiley +1 more source
S index: a predictor comparable to ultrasound shear wave elastography in assessing liver fibrosis in patients with chronic hepatitis B. [PDF]
Guo S+9 more
europepmc +1 more source
Prevalence of oral submucous fibrosis among 50,915 Indian villagers
J. J. Pindborg+3 more
openalex +1 more source
This study constructs a stacked multimodal machine learning model for nonalcoholic fattly liver disease (NAFLD) by integrating genetic and clinical features, and synthesize an in‐silico quantitative marker (ISNLD) that enables personalized risk stratification for intrahepatic and extrahepatic outcomes of high‐risk individuals of NAFLD.
Lushan Xiao+14 more
wiley +1 more source
Protocollagen Proline Hydroxylase in Normal Liver and in Hepatic Fibrosis
Tadashi Takeuchi, Darwin J. Prockop
openalex +1 more source